The expression of hCG receptor mRNA in four human ovarian cancer cell lines varies considerably under different experimental conditions

Tumor Biology

Volumn 24, Issue 1, 2003, Pages 13-22

  Steinmeyer, Christoph ^a   Berkholz, Alexander ^a   Gebauer, Gerhard ^a   Jäger, Wolfram ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b High Tech Clinic   (Germany)

Author keywords

Alternative splicing; Gonadotropins; Luteinizing hormone human chorionic gonadotropin receptor; Ovarian cancer

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; COMPLEMENTARY DNA; DNA FRAGMENT; MESSENGER RNA; PRIMER RNA;

AGAR GEL ELECTROPHORESIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SPLICING; DNA TRANSCRIPTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; MEDICAL ASSESSMENT; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING;

EID: 0037570828     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070656     Document Type: Article

References (52)

1. Biskind MS, Biskind GS: Development of tumors in the rat ovary after transplantation into the spleen. Proc Soc Exp Biol Med 1944;55:176-179.
2. Jäger W, Dittrich R, Recabarren S, Wildt L, Lang N: Induction of ovarian tumors by endogenous gonadotropins in rats bearing intrasplenic ovarian grafts. Tumor Biol 1995;16:268-280.
3. Kurbacher CM, Jäger W, Kurbacher JA, Bittl A, Wildt L, Lang N: Influence of human luteinizing hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro. Tumor Biol 1995;16:374-384.
4. Simon WE, Albrecht M, Hänsel M, Dietel M, Hölzel F: Cell lines derived from human ovarian carcinomas: Growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 1983;70:839-845.
5. Ohtani K, Sakamoto H, Satoh K: Stimulatory effects of follicular stimulating hormone on the proliferation of ovarian cancer cell line in vitro and in vivo. Nippon Sanka Fujinka Gakkai Zasshi 1992;44:717-724.
6. Kataoka A, Nishida T, Motomura S, Higashijima T, Ueyama T, Sugiyama T, Yakushiji M: The effects of sex steroid hormones, gonadotropins, and gonadotropin releasing hormone agonist on the proliferation of ovarian cancer cell line (KOC-2S). Nippon Sanka Fujinka Gakkai Zasshi 1994;46:1033-1040.
7. de Jong J, Nap M, Merz WE, Leunissen JE, Jäger W: Direct gold-silver method for hCG binding to specific tissue structures. J Histotechnol 1992;15:275-281.
8. McFarland KC, Sprengel R, Phillips HS, Köhler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH: Lutropin-choriogonadotropin receptor: An unusual member of the G protein-coupled receptor family. Science 1989;245:494-499.
9. Minegishi T, Nakamura K, Takakura Y, Miyamoto K, HasegawaY, Ibuki Y, Igarashi M: Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun 1990;172:1049-1054.
10. Koo YB, Ji I, Slaughter RG, Ji TH: Structure of the luteinizing hormone receptor gene and multiple exons of the coding sequence. Endocrinology 1991;128:2297-2308.
11. Tsai-Morris CH, Buczko E, Wang W, Xie XZ, Dufau ML: Structural organization of the rat luteinizing hormone (LH) receptor gene. J Biol Chem 1991;266:11355-11359.
12. Segaloff DL, Ascoli M: The lutropin/choriogonadotropin receptor ... 4 years later. Endocr Rev 1993;14:324-347.
13. Hipkin RW, Sánchez-Yagüe J, Ascoli M: Agonist-induced phosphorylation of the luteinizing hormone/chorionic gonadotropin receptor expressed in a stably transfected cell line. Mol Endocrinol 1993;7:823-832.
14. Ascoli M: Lysosomal accumulation of the hormone-receptor complex during receptor-mediated endocytosis of human choriogonadotropin. J Cell Biol 1984;99(4Pt1):1242-1250.
15. Hoffman YM, Peegel H, Sprock MJ, Zhang QY Menon KM: Evidence that human chorionic gonadotropin/luteinizing hormone receptor down-regulation involves decreased levels of receptor messenger ribonucleic acid. Endocrinology 1991;128:388-393.
16. La Polt PS, Jia XC, Sincich C, Hsueh AJ: Ligand-induced down-regulation of testicular and ovarian luteinizing hormone (LH) receptors is preceded by tissue-specific inhibition of alternatively processed receptor transcripts. Mol Endocrinol 1991;5:397-403.
17. Wang H, Segaloff DL, Ascoli M: Lutropin/choriogonadotropin down-regulates its receptor by both receptor-mediated endocytosis and a cAMP-dependent reduction in receptor mRNA. J Biol Chem 1991;266:780-785.
18. Wang H, Segaloff DL, Ascoli M: Epidermal growth factor and phorbol esters reduce the levels of the cognate mRNA for the LH/CG receptor. Endocrinology 1991;128:2651-2653.
19. Nelson S, Ascoli M: Epidermal growth factor, a phorbol ester, and 3′,5′-cyclic adenosine monophosphate decrease the transcription of the luteinizing hormone/chorionic gonadotropin receptor gene in MA-10 Leydig tumor cells. Endocrinology 1992;131:615-620.
20. Lu DL, Peegel H, Mosier SM, Menon KM: Loss of lutropin/human choriogonadotropin receptor messenger ribonucleic acid during ligand-induced down-regulation occurs post transcriptionally. Endocrinology 1993;132:235-240.
21. Segaloff DL, Wang HY, Richards JS: Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Mol Endocrinol 1990;4:1856-1865.
22. LaPolt PS, Oikawa M, Jia XC, Dargan C, Hsueh AJ: Gonadotropin-induced up- and down-regulation of rat ovarian LH receptor message levels during follicular growth, ovulation and luteinization. Endocrinology 1990;126:3277-3279.
23. Yamoto M, Shima K, Nakano R: Gonadotropin receptors in human ovarian follicles and corpora lutea throughout the menstrual cycle. Horm Res 1992;37(suppl 1):5-11.
24. Camp TA, Rahal JO, Mayo KE: Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. Mol Endocrinol 1991;5:1405-1417.
25. Peng XR, Hsueh AJ, LaPolt PS, Bjersing L, Ny T: Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology 1991;129:3200-3207.
26. Licht P, Wildt L: Gonadal and extragonadal receptors for human chorionic gonadotropin and luteinizing hormone. Assist Reprod Rev 1998;8:152-172.
27. Lin J, Lei ZM, Lojun S, Rao CV, Satyaswaroop PG, Day TG: Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 1994;79:1483-1491.
28. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E: Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997;57:857-864.
29. Kammerman S, Demopoulos RI, Raphael C, Ross J: Gonadotropic hormone binding to human ovarian tumors. Hum Pathol 1981;12:886-890.
30. Rajaniemi H, Kauppila A, Rönnberg L, Selander K, Pystynen P: LH(hCG) receptor in benign and malignant tumors of human ovary. Acta Obstet Gynecol Scand Suppl 1981;101:83-86.
31. Nakano R, Kitayama S, Yamoto M, Shima K, Ooshima A: Localization of gonadotropin binding sites in human ovarian neoplasms. Am J Obstet Gynecol 1989;161:905-910.
32. Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S, Nanbu K, Rao CV, Mori T: Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 1997;33:1501-1507.
33. Lu JJ, Zheng Y, Kang X, Yuan JM, Lauchlan SC, Pike MC, Zheng W: Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Gynecol Oncol 2000;79:158-168.
34. Reinholz MM, Zschunke MA, Roche PC: Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary. Gynecol Oncol 2000;79:264-271.
35. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF: Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 1983;43:5379-5389.
36. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning - A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
37. Piquette GN, LaPolt PS, Oikawa M, Hsueh AJ: Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells. Endocrinology 1991;128:2449-2456.
38. Zheng W, Magid MS, Kramer EE, Chen YT: Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 1996;148:47-53.
39. Zheng W, Lu JJ, Luo F, Zheng Y, Feng YJ, Felix JC, Lauchlan SC, Pike MC: Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol 2000;76:80-88.
40. Smith CW, Patton JG, Nadal-Ginard B: Alternative splicing in the control of gene expression. Annu Rev Genet 1989;23:527-577.
41. Minegishi T, Tano M, Abe Y, Nakamura K, Ibuki Y, Miyamoto K: Expression of luteinizing hormone/human chorionic gonadotropin (LH/HCG) receptor mRNA in the human ovary. Mol Hum Reprod 1997;3:101-107.
42. Wang H, Ascoli M, Segaloff DL: Multiple luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid transcripts. Endocrinology 1991;129:133-138.
43. Aatsinki JT, Pietilä EM, Lakkakorpi JT, Rajaniemi HJ: Expression of the LH/CG receptor gene in rat ovarian tissue is regulated by an extensive alternative splicing of the primary transcript. Mol Cell Endocrinol 1992;84:127-135.
44. Bacich DJ, Rohan RM, Norman RJ, Rodgers RJ: Characterization and relative abundance of alternatively spliced luteinizing hormone receptor messenger ribonucleic acid in the ovine ovary. Endocrinology 1994;135:735-744.
45. Koo YB, Ji I, Ji TH: Characterization of different sizes of rat luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acids. Endocrinology 1994;134:19-26.
46. Braun T, Schofield PR, Sprengel R: Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 1991;10:1885-1890.
47. Segaloff DL, Sprengel R, Nikolics K, Ascoli M: The structure of the lutropin/choriogonadotropin receptor. Recent Prog Horm Res 1990;46:261-303.
48. Xie YB, Wang H, Segaloff DL: Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem 1990;265:21411-21414.
49. Moyle WR, Bernard MP, Myers RV, Marko OM, Strader CD: Lutropin/β-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface. J Biol Chem 1991;266:10807-10812.
50. Licht P, Cao H, Lei ZM, Rao CV, Merz WE: Novel self-regulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta. Endocrinology 1993;133:3014-3025.
51. Thomas DM, Segaloff DL: Hormone-binding properties and glycosylation pattern of a recombinant form of the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor expressed in mammalian cells. Endocrinology 1994;135:1902-1912.
52. Atger M, Misrahi M, Sar S, Le Flem L, Dessen P, Milgrom E: Structure of the human luteinizing hormone-choriogonadotropin receptor gene: Unusual promoter and 5′ non-coding regions. Mol Cell Endocrinol 1995;111:113-123.